SCHEMBL1852188

SCHEMBL1852188

O=c1[nH]c([C@@H]2CCCN2)nc2c1oc1ccccc12

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 14/20 0.72
CSNK2B P67870 14/20 0.72
CDC7 O00311 13/20 0.72
CSNK2A1 P68400 13/20 0.72
CSNK2A2 P19784 2/20 0.72
CIT O14578 1/20 0.72
CYP1A2 P05177 1/20 0.72
GSK3B P49841 1/20 0.72
DYRK1A Q13627 1/20 0.72
CSNK2A3 Q8NEV1 1/20 0.72
TAOK3 Q9H2K8 1/20 0.72
ALDH1A1 P00352 1/20 0.51
GLA P06280 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
MAPT P10636 1/20 0.49
PKM P14618 1/20 0.49
PIM3 Q86V86 1/20 0.48
PIM2 Q9P1W9 1/20 0.48
MAPK1 P28482 1/20 0.46
KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1848525 0.84 PIM1 (1.00) PIM1CSNK2BCDC7CSNK2A1CSNK2A2
Bms-863233 SCHEMBL1853714 0.84 PIM1 (1.00) PIM1CSNK2BCDC7CSNK2A1CSNK2A2
Bms-863233 SCHEMBL30633417 0.84 PIM1 (1.00) PIM1CSNK2BCDC7CSNK2A1CSNK2A2
SCHEMBL1851666 0.84 PIM1 (1.00) PIM1CSNK2BCDC7CSNK2A1CSNK2A2
SCHEMBL12661278 0.84 PIM1 (0.77) PIM1CSNK2BCDC7CSNK2A1CSNK2A2
SCHEMBL1852667 0.84 PIM1 (1.00) PIM1CSNK2BCDC7CSNK2A1CSNK2A2
Bms-863233 SCHEMBL31060508 0.84 PIM1 (1.00) PIM1CSNK2BCDC7CSNK2A1CSNK2A2
Bms-863233 SCHEMBL1850034 0.83 PIM1 (0.98) PIM1CSNK2BCDC7CSNK2A1CSNK2A2
Bms-863233 SCHEMBL29467549 0.83 PIM1 (0.98) PIM1CSNK2BCDC7CSNK2A1CSNK2A2
Bms-863233 SCHEMBL30218230 0.83 PIM1 (0.98) PIM1CSNK2BCDC7CSNK2A1CSNK2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2097419-B1 BENZOFUROPYRIMIDINONES AS PROTEIN KINASE INHIBITORS EXELIXIS INC (US) 2011-05-25 EP claimed
EP-2097419-B1 BENZOFUROPYRIMIDINONES AS PROTEIN KINASE INHIBITORS EXELIXIS INC (US) 2011-05-25 EP disclosed
EP-2097419-B1 BENZOFUROPYRIMIDINONES AS PROTEIN KINASE INHIBITORS EXELIXIS INC (US) 2011-05-25 EP disclosed
US-20090247559-A1 Benzofuropyrimidinones EXELIXIS, INC. (US) 2009-10-01 US disclosed
US-20090247559-A1 Benzofuropyrimidinones EXELIXIS, INC. (US) 2009-10-01 US disclosed
US-20090247559-A1 Benzofuropyrimidinones EXELIXIS, INC. (US) 2009-10-01 US disclosed
EP-2097419-A1 BENZOFUROPYRIMIDINONES AS PROTEIN KINASE INHIBITORS Exelixis, Inc. (US) 2009-09-09 EP disclosed
WO-2009086264-A1 BENZOFUROPYRIMIDINONES AS PROTEIN KINASE INHIBITORS EXELIXIS, INC. (US) 2009-07-09 WO disclosed
WO-2009086264-A1 BENZOFUROPYRIMIDINONES AS PROTEIN KINASE INHIBITORS EXELIXIS, INC. (US) 2009-07-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247559-A1 Benzofuropyrimidinones F12, BRI3BP, BRD1 PIM1 1977/4885CSNK2B 350/4885CDC7 3933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.